Inventor
BONNY CHRISTOPHE
CH31 patents
⚠️ This page may combine multiple inventors who share the name “BONNY CHRISTOPHE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BONNY CHRISTOPHE
11 patentsUS7034109B2Apr 25, 2006
Intracellular delivery of biological effectors
BONNY CHRISTOPHE36 citations96
US10023615B2Jul 17, 2018
Efficient transport into white blood cells
BONNY CHRISTOPHE33 citations94
US8278413B2Oct 2, 2012
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
BONNY CHRISTOPHE23 citations92
US8236924B2Aug 7, 2012
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
BONNY CHRISTOPHE19 citations92
US9180159B2Nov 10, 2015
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
BONNY CHRISTOPHE8 citations84
US9006185B2Apr 14, 2015
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
BONNY CHRISTOPHE7 citations84
US8981052B2Mar 17, 2015
JNK inhibitor molecules
BONNY CHRISTOPHE9 citations84
US8748395B2Jun 10, 2014
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
BONNY CHRISTOPHE11 citations84
US8569447B2Oct 29, 2013
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
BONNY CHRISTOPHE9 citations84
US8183339B1May 22, 2012
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
BONNY CHRISTOPHE15 citations84
US8080517B2Dec 20, 2011
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
BONNY CHRISTOPHE17 citations84
UNIV LAUSANNE
4 patentsUS6960648B2Nov 1, 2005
Intracellular delivery of biological effectors
UNIV LAUSANNE142 citations99
US6610820B1Aug 26, 2003
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
UNIV LAUSANNE63 citations96
US6780970B2Aug 24, 2004
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
UNIV LAUSANNE29 citations92
US7033597B2Apr 25, 2006
Intracellular delivery of biological effectors
UNIV LAUSANNE5 citations63
XIGEN SA
4 patentsUS7943574B2May 17, 2011
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
XIGEN SA15 citations92
US7635681B2Dec 22, 2009
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
XIGEN SA28 citations92
US7538091B2May 26, 2009
Intracellular delivery of biological effectors
XIGEN SA9 citations83
US7803749B2Sep 28, 2010
Peptide inhibitors of MKK7 kinase binding to insulin binding proteins
XIGEN SA6 citations73
XIGEN INFLAMMATION LTD
3 patentsUS9610330B2Apr 4, 2017
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
XIGEN INFLAMMATION LTD5 citations83
US9290538B2Mar 22, 2016
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
XIGEN INFLAMMATION LTD5 citations83
US9624267B2Apr 18, 2017
JNK inhibitor molecules
XIGEN INFLAMMATION LTD5 citations72
PHI PHARMA SA
3 patentsENTEROME S A
3 patentsUS12016910B2Jun 25, 2024
Antigenic peptides for prevention and treatment of cancer
ENTEROME S A1 citations59
US12364743B2Jul 22, 2025
Microbiota sequence variants of tumor-related antigenic epitopes
ENTEROME S A0 citations55
US11712465B2Aug 1, 2023
Microbiota sequence variants of tumor-related antigenic epitopes
ENTEROME S A1 citations55